Pang Yao

Pang Yao is a Senior Molecular Epidemiologist and co-leader of the Diabetes Theme in the China Kadoorie Biobank (CKB). He completed his PhD in Biochemistry and Molecular Biology at the Chinese Academy of Sciences.

His research is centered on developing upstream high-throughput multi-omics discovery pipelines—such as genomics, proteomics, metabolomics, serolomics, and phenomics—and downstream screening methodologies using bioinformatics and machine learning approaches. These efforts are applied to diverse populations, including those in the CKB and UK Biobank (UKB), with the goal of identifying novel pathways and potential therapeutic targets for adiposity and cardiometabolic diseases, such as type 2 diabetes, stroke, heart failure, and ischemic heart disease.